Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. - Wikidata - wikimedia - TriplyDB

Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.

Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33385646

about

Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia Chlorambucil for patients with primary biliary cirrhosis The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association data Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemia Current concepts in diagnosis and treatment of chronic lymphocytic leukemia Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies Ultrasound-mediated drug delivery for cardiovascular disease.Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms.Treatment of synchronous mantle cell lymphoma and small lymphocytic lymphoma with bendamustine and rituximab.Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals.Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia.Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG).Retreatment with bendamustine-containing regimens in patients with relapsed/refractory chronic lymphocytic leukemia and indolent B-cell lymphomas achieves high response rates and some long lasting remissions.Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia.Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis.The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.Open-label bendamustine monotherapy for pediatric patients with relapsed or refractory acute leukemia: efficacy and tolerability.Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes An evaluation of the potential for drug-drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma.Management of chronic lymphocytic leukemia.Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndrome.Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab.Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia.Pharmacokinetics and excretion of 14C-bendamustine in patients with relapsed or refractory malignancy The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia.Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II study.

P2860

Q24200280-A7EF6894-7E9D-41A7-B8B1-B11B5A61B6F3 Q24200307-CE3A9288-5F3F-4D0D-9FD8-F36E49928D3D Q24605471-DFD3D6D0-609F-4717-BD00-3DBDA906B20C Q26738934-7CEB3FC8-3F7E-4E4B-AB60-AFA22B9EAD7A Q26744365-E0A35CBA-BD74-41B1-A021-6DCAE8ACF8BA Q26770471-51D05017-7856-484D-9627-03222C5DF641 Q26781163-1689C755-F9EA-4822-9D66-994723493533 Q27002428-5E0E2D51-7049-4319-BC13-A8C65EAE537F Q27011795-BE2E790A-D2E7-4864-81EB-0BA7616213F1 Q28082086-D14D8D9C-2412-47F9-BC30-1707FCAF6095 Q28540830-49E47DA6-B632-437F-930F-C2ED0DD543A9 Q30438336-068CFC58-F137-4841-84A4-1B0F2BC73A25 Q30801095-8B88E815-823C-4C96-9447-30D34B072BA3 Q33394623-074F6091-6A38-4DC0-AC68-3B3423911EDE Q33394853-3452B74D-633F-44CC-91AE-C1DD021216BC Q33399400-93FD5649-1573-4F3E-B30E-8D92ACDA18C2 Q33401132-96F9E567-8879-4283-A1AA-E518C5D04805 Q33404350-37DE143D-313D-4563-BB45-CED270765983 Q33405428-B1DD996F-CC55-4A42-B094-265CA461352E Q33406478-0EFCCDD8-074C-4B1D-95E9-C2DB5B699374 Q33410064-4DF5C499-277B-416D-9610-733C3B623224 Q33410592-718AA3CE-288B-40F1-A2D5-D31A694F2B86 Q33412064-244FCE87-5671-4492-8D63-B17458F2B3A1 Q33414468-C534E447-7A98-40EB-9433-35F1A3736DD1 Q33416982-AADB72CE-89AE-4982-92F9-CFBF8DBCF997 Q33425372-7497487D-64F7-44F1-A517-63D886C032CE Q33558148-815138DE-CBFB-434B-8013-376A35D6491B Q33656746-DDDCDC08-2451-4AFD-9807-0855155A631D Q33695912-114DBF52-32D4-4336-89B7-94C936F7C038 Q33730841-4184E026-8EB9-4951-8010-DF3F60348236 Q33749652-54C81239-98FF-4CEA-9E34-23AADB5EA9EE Q33903379-503ECA23-2BC1-43D3-A474-1FC60E5C3A50 Q33956034-E2AF69E9-28CA-4942-9939-B05AA71EC8DD Q34008584-F65E0CC5-BE1B-40C6-88C5-216C91549982 Q34009041-76E2B766-4ECB-46A0-809C-8B804B448CB2 Q34322781-6628D6F1-A801-46CF-A5A0-4A2654F27B5D Q34418442-DE4054F0-F937-40C1-800C-CADEEB0370D2 Q34663603-A8FB3DF3-C363-4ED1-93CA-A5259B5F19FB Q35114910-E923B541-D20A-4C35-A555-EAA21A87FA9A Q35123154-B4DD6FAF-0E08-4188-BFE0-C3020C662781

P2860

Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33385646

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Phase III randomized study of ...... chronic lymphocytic leukemia.

@ast

Phase III randomized study of ...... chronic lymphocytic leukemia.

@en

type

label

Phase III randomized study of ...... chronic lymphocytic leukemia.

@ast

Phase III randomized study of ...... chronic lymphocytic leukemia.

@en

prefLabel

Phase III randomized study of ...... chronic lymphocytic leukemia.

@ast

Phase III randomized study of ...... chronic lymphocytic leukemia.

@en

P1433

Q33385646-25B9F733-A5A5-4AB3-8BFE-AD485B85F825

P1476

Q33385646-FE13CBF8-2CCB-494E-A19B-BB198466337D

P2093

Q33385646-06993385-A10B-4C9F-B7CE-ED9CA4925027

Q33385646-08F2646F-C226-4C47-8CA1-BD4293850110

Q33385646-14143A64-31E1-4B95-BFD5-A3AE237F5CF0

Q33385646-1D79ADBA-EC3B-4C2A-864B-2DFE74DA97C8

Q33385646-226C0919-BBA8-40AB-A164-6E87E7D34B88

Q33385646-2A50F47A-8D06-42E9-BDF7-30E16048679C

Q33385646-388A04D2-F825-4A22-BEE6-2D9C7748C8A4

Q33385646-4CF11097-7629-48A4-828F-6A7B5E22A0AC

Q33385646-58B80CD5-1631-440A-915C-18F0795F3C23

Q33385646-93B21A3A-85FB-404F-A0FC-4D8BF9EE4356

P304

Q33385646-8A02A043-297E-4A0A-A05D-1BFE3A68610A

P31

Q33385646-FC54B1C4-BBF7-4619-BE24-13FBF10554D2

P356

Q33385646-FB962F86-4D8B-4186-AF08-47493676A54B

P407

Q33385646-D8A9628D-8BD4-4B5C-81C5-267887AE2A6C

P433

Q33385646-278DCC86-C72A-4A22-909D-3D409A7820C5

P478

Q33385646-35D54C66-5EFB-48A4-9BE0-2998CA490D87

P50

Q33385646-1B672608-B010-4D6B-A3ED-70139113E00F

Q33385646-307B7247-2AA3-48B7-BE54-7F6C220AD933

P577

Q33385646-C097A9BC-9F06-448E-A2E7-9CBC8A201F3C

P698

Q33385646-1D53F7E3-0634-43BF-BC40-A04E993C33CB

P921

Q33385646-A587C1E5-450E-4DB0-94FB-326C62193CA4

Q33385646-DCA88BAA-280A-4E32-A4E8-F8B7D9B10D79

P356

JCO.2008.20.8389

P1433

Journal of Clinical Oncology

P1476

Phase III randomized study of ...... chronic lymphocytic leukemia.

@en

P2093

Ali Aldaoud

http://www.w3.org/2001/XMLSchema#string

Anna Liberati

http://www.w3.org/2001/XMLSchema#string

Francoise Huguet

http://www.w3.org/2001/XMLSchema#string

Gerhard Postner

http://www.w3.org/2001/XMLSchema#string

Gunnar Juliusson

http://www.w3.org/2001/XMLSchema#string

Hans-Joerg Fricke

http://www.w3.org/2001/XMLSchema#string

Ilaria Del Giudice

http://www.w3.org/2001/XMLSchema#string

Javier Loscertales

http://www.w3.org/2001/XMLSchema#string

Karlheinz Merkle

http://www.w3.org/2001/XMLSchema#string

Lothar Tremmel

http://www.w3.org/2001/XMLSchema#string

P304

4378-4384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.20.8389

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Raoul Herbrecht

P577

2009-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19652068

http://www.w3.org/2001/XMLSchema#string

P921